Molecular pharmacology of the onco-TRP channel TRPV6

References

• Neuberger A, Nadezhdin KD, Sobolevsky AI. Methods Enzymol. Vol. 652, 31–20. Elsevier; 2021
   Google Scholar
• Hoenderop JG, Vennekens R, Muller D, et al. Function and expression of the epithelial Ca2+ channel family: comparison of mammalian ECaC1 and 2. J Physiol. 2001;537(3):747–761. doi: 10.1113/jphysiol.2001.012917
   PubMed Web of Science ®Google Scholar
• Vennekens R, Voets T, Bindels RJ, et al. Current understanding of mammalian TRP homologues. Cell Calcium. 2002;31(6):253–264. pii. doi: 10.0143/4160(02)00055-6.
   PubMed Web of Science ®Google Scholar
• den Dekker E, Hoenderop JG, Nilius B, et al. The epithelial calcium channels, TRPV5 & TRPV6: from identification towards regulation. Cell Calcium. 2003;33:497–507. pii. doi: 10.0143/416003000654
   PubMed Web of Science ®Google Scholar
• Fecher-Trost C, Weissgerber P, Wissenbach U. TRPV6 channels. Mammalian Transient Receptor Potential (TRP) Cation Channels. 2014;359–384.
   Google Scholar
• Zakharian E, Cao C, Rohacs T. Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5) P2. FASEB J. 2011;25:3915–3928. doi: 10.1096/fj.11-184630
   PubMed Web of Science ®Google Scholar
• Cai R, Liu X, Zhang R, et al. Autoinhibition of TRPV6 channel and regulation by PIP2. iScience. 2020;23(9):101444. doi: 10.1016/j.isci.2020.101444
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Lukacs V, Rohacs T. Hydrolysis of phosphatidylinositol 4,5-bisphosphate mediates calcium-induced inactivation of TRPV6 channels. J Biol Chem. 2008;283(22):14980–14987. doi: 10.1074/jbc.M704224200
   PubMed Web of Science ®Google Scholar
• Voets T, Janssens A, Prenen J, et al. Mg2+-dependent gating and strong inward rectification of the cation channel TRPV6. J Gen Physiol. 2003;121:245–260. doi: 10.1085/jgp.20028752
   PubMed Web of Science ®Google Scholar
• Owsianik G, Talavera K, Voets T, et al. Permeation and selectivity of TRP channels. Annu Rev Physiol. 2006;68(1):685–717. doi: 10.1146/annurev.physiol.68.040204.101406
   PubMedGoogle Scholar
• Lambers TT, Weidema AF, Nilius B, et al. Regulation of the mouse epithelial Ca2+ channel TRPV6 by the Ca2+-sensor calmodulin. J Biol Chem. 2004;279(28):28855–28861. doi: 10.1074/jbc.M313637200
   PubMed Web of Science ®Google Scholar
• Derler I, Hofbauer M, Kahr H, et al. Dynamic but not constitutive association of calmodulin with rat TRPV6 channels enables fine tuning of Ca2+-dependent inactivation. J Physiol. 2006;577:31–44. doi: 10.1113/jphysiol.2006.118661
   PubMed Web of Science ®Google Scholar
• Nilius B, Prenen J, Hoenderop JG et al. Fast and slow inactivation kinetics of the Ca2+ channels ECaC1 and ECaC2 (TRPV5 and TRPV6). Role of the intracellular loop located between transmembrane segments 2 and 3. J Biol Chem. 2002;277:30852–30858. doi: 10.1074/jbc.M202418200
   PubMed Web of Science ®Google Scholar
• Singh AK, McGoldrick LL, Twomey EC, et al. Mechanism of calmodulin inactivation of the calcium-selective TRP channel TRPV6. Sci Adv. 2018;4(8):eaau6088. doi: 10.1126/sciadv.aau6088
   PubMed Web of Science ®Google Scholar
• Khattar V, Wang L, Peng J-B. Calcium selective channel TRPV6: Structure, function, and Implications in health and disease. Gene. 2022;817:146192. doi: 10.1016/j.gene.2022.146192
   PubMed Web of Science ®Google Scholar
• Yelshanskaya MV, Nadezhdin KD, Kurnikova MG, et al. Structure and function of the calcium‐selective TRP channel TRPV6. Journal Of Physiology. 2021;599(10):2673–2697. doi: 10.1113/JP279024
   PubMed Web of Science ®Google Scholar
• Walker V, Vuister GW. Biochemistry and pathophysiology of the transient potential receptor vanilloid 6 (TRPV6) calcium channel. Adv Clin Chem. 2023;113:43–100. doi: 10.1016/bs.acc.2022.11.002
   PubMedGoogle Scholar
• Peng JB, Chen XZ, Berger UV, et al. Human calcium transport protein CaT1. Biochem Biophys Res Commun pii. 2000;278:326–332. doi: 10.1006/bbrc.2000.3716
   PubMed Web of Science ®Google Scholar
• Hirnet D, Olausson J, Fecher-Trost C, et al. The TRPV6 gene, cDNA and protein. Cell Calcium. 2003;33(5–6):509–518. doi: 10.1016/S0143-4160(03)00066-6
   PubMed Web of Science ®Google Scholar
• Semenova SB, Vassilieva IO, Fomina AF, et al. Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. Am J Physiol Cell Physiol. 2009;296(5):C1098–1104. pii. doi: 10.1152/ajpcell.00435.200800435.2008.
   PubMed Web of Science ®Google Scholar
• Giusti L, Cetani F, Da Valle Y, et al. First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. J Cell Mol Med. 2014;18(10):1944–1952. doi: 10.1111/jcmm.12372
   PubMed Web of Science ®Google Scholar
• Wartenberg P, Lux F, Busch K, et al. A TRPV6 expression atlas for the mouse. Cell Calcium. 2021;100:102481. doi: 10.1016/j.ceca.2021.102481
   PubMed Web of Science ®Google Scholar
• Wissenbach U, Niemeyer BA, Fixemer T, et al. Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. J Biol Chem. 2001;276(22):19461–19468. doi: 10.1074/jbc.M009895200
   PubMed Web of Science ®Google Scholar
• Peng JB, Chen X-Z, Berger UV, et al. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem. 1999;274(32):22739–22746. doi: 10.1074/jbc.274.32.22739
   PubMed Web of Science ®Google Scholar
• Bianco SD, Peng J-B, Takanaga H, et al. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Mineral Res. 2007;22(2):274–285. doi: 10.1359/jbmr.061110
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Kovacs CS, Takanaga, H et al. Calcium channel TRPV6 is involved in murine maternal–fetal calcium transport. J Bone Mineral Res. 2008;23:1249–1256. doi: 10.1359/jbmr.080314
   PubMed Web of Science ®Google Scholar
• Weissgerber P, Kriebs U, Tsvilovskyy V, et al. Excision of Trpv6 gene leads to severe defects in epididymal Ca2+ absorption and male fertility much like single D541A pore mutation. J Biol Chem. 2012;287(22):17930–17941. doi: 10.1074/jbc.M111.328286
   PubMed Web of Science ®Google Scholar
• Weissgerber P, Kriebs U, Tsvilovskyy V, et al. Male fertility depends on Ca2+ absorption by TRPV6 in epididymal epithelia. Sci Signaling. 2011;4(171):ra27–ra27. doi: 10.1126/scisignal.2001791
   PubMed Web of Science ®Google Scholar
• Lieben L, Benn BS, Ajibade D, et al. Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis. Bone. 2010;47(2):301–308. doi: 10.1016/j.bone.2010.04.595
   PubMed Web of Science ®Google Scholar
• Wangemann P, Nakaya K, Wu T, et al. Loss of cochlear HCO3− secretion causes deafness via endolymphatic acidification and inhibition of Ca2+ reabsorption in a Pendred syndrome mouse model. Am J Physiol Renal Physiol. 2007;292(5):F1345–F1353. doi: 10.1152/ajprenal.00487.2006
   PubMed Web of Science ®Google Scholar
• Huybers S, Apostolaki M, van der Eerden BC, et al. Murine TNF ΔARE Crohn’s disease model displays diminished expression of intestinal Ca2+ transporters. Inflamm Bowel Dis. 2008;14:803–811. doi: 10.1002/ibd.20385
   PubMed Web of Science ®Google Scholar
• Wu G, Zhang W, Na T, et al. Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease. Am J Physiol Cell Physiol. 2012;302(10):C1479–C1491. doi: 10.1152/ajpcell.00277.2011
   PubMed Web of Science ®Google Scholar
• Yang SS, Lo Y-F, Yu I-S, et al. Generation and analysis of the thiazide‐sensitive Na+‐Cl− cotransporter (Ncc/Slc12a3) Ser707X knockin mouse as a model of Gitelman syndrome. Human Mutation. 2010;31(12):1304–1315. doi: 10.1002/humu.21364
   PubMed Web of Science ®Google Scholar
• Frick KK, Asplin JR, Favus MJ, et al. Increased biological response to 1,25(OH)2D3 in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol. 2013;304(6):F718–F726. doi: 10.1152/ajprenal.00645.2012
   PubMed Web of Science ®Google Scholar
• Haché S, Takser L, LeBellego F, et al. Alteration of calcium homeostasis in primary preeclamptic syncytiotrophoblasts: effect on calcium exchange in placenta. J Cell Mol Med. 2011;15(3):654–667. doi: 10.1111/j.1582-4934.2010.01039.x
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Chitayat D, Sawada H, et al. TRPV6 variants interfere with maternal-fetal calcium transport through the placenta and cause transient neonatal hyperparathyroidism. Am J Hum Genet. 2018;102(6):1104–1114. doi: 10.1016/j.ajhg.2018.04.006
   PubMed Web of Science ®Google Scholar
• Burren CP, Caswell R, Castle B, et al. TRPV6 compound heterozygous variants result in impaired placental calcium transport and severe undermineralization and dysplasia of the fetal skeleton. Am J Med Genet A. 2018;176(9):1950–1955. doi: 10.1002/ajmg.a.40484
   PubMed Web of Science ®Google Scholar
• Nett V, Erhardt N, Wyatt A, et al. Human TRPV6-pathies caused by gene mutations. Biochim Biophys Acta. 2021;1865(6):129873. doi: 10.1016/j.bbagen.2021.129873
   Web of Science ®Google Scholar
• Masamune A, Kotani H, Sörgel FL, et al. Variants that affect function of calcium channel TRPV6 are associated with early-onset chronic pancreatitis. Gastroenterology. 2020;158(6):1626–1641. e1628. doi: 10.1053/j.gastro.2020.01.005
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Sawada H, Tokumasu T, et al. Novel TRPV6 mutations in the spectrum of transient neonatal hyperparathyroidism. J Physiol Sci. 2020;70(1):1–10. doi: 10.1186/s12576-020-00761-2
   PubMed Web of Science ®Google Scholar
• Yamashita S, Mizumoto H, Sawada H, et al. TRPV6 gene mutation in a dizygous twin with transient neonatal hyperparathyroidism. J Endocr Soc. 2019;3(3):602–606. doi: 10.1210/js.2018-00374
   PubMed Web of Science ®Google Scholar
• Zou WB, Wang Y-C, Ren X-L, et al. TRPV6 variants confer susceptibility to chronic pancreatitis in the Chinese population. Human Mutation. 2020;41(8):1351–1357. doi: 10.1002/humu.24032
   PubMed Web of Science ®Google Scholar
• Stewart JM. TRPV6 as a target for cancer therapy. J Cancer. 2020;11(2):374. doi: 10.7150/jca.31640
   PubMed Web of Science ®Google Scholar
• Peng J-B, Zhuang L, Berger UV, et al. CaT1 expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun. 2001;282(3):729–734. doi: 10.1006/bbrc.2001.4638
   PubMed Web of Science ®Google Scholar
• Fixemer T, Wissenbach U, Flockerzi V, et al. Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene. 2003;22(49):7858–7861. doi: 10.1038/sj.onc.1206895
   PubMed Web of Science ®Google Scholar
• Zhuang L, Peng J-B, Tou L, et al. Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest. 2002;82(12):1755–1764. doi: 10.1097/01.LAB.0000043910.41414.E7
   PubMed Web of Science ®Google Scholar
• Peleg S, Sellin JH, Wang Y, et al. Suppression of aberrant transient receptor potential cation channel, subfamily V, member 6 expression in hyperproliferative colonic crypts by dietary calcium. Am J Physiol Gastrointest Liver Physiol. 2010;299(3):G593–G601. doi: 10.1152/ajpgi.00193.2010
   PubMed Web of Science ®Google Scholar
• Xu X, Li N, Wang Y, et al. Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP. Cancer Lett. 2021;519:150–160. doi: 10.1016/j.canlet.2021.07.017
   PubMed Web of Science ®Google Scholar
• Peters AA, Simpson PT, Bassett JJ, et al. Calcium channel TRPV6 as a potential therapeutic target in Estrogen receptor–Negative breast Cancer Characterization of TRPV6 in breast cancer. Mol Cancer Ther. 2012;11(10):2158–2168. doi: 10.1158/1535-7163.MCT-11-0965
   PubMed Web of Science ®Google Scholar
• Dhennin-Duthille I, Gautier M, Faouzi M, et al. High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol Biochem. 2011;28(5):813–822. doi: 10.1159/000335795
   PubMedGoogle Scholar
• Francis-Lyon PA, Malik F, Cheng X, et al. TRPV6 as a putative genomic susceptibility locus influencing racial disparities in cancer. Cancer Prev Res. 2020;13(5):423–428. doi: 10.1158/1940-6207.CAPR-19-0351
   PubMed Web of Science ®Google Scholar
• Haverstick DM, Heady TN, Macdonald TL, et al. Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. Cancer Res. 2000;60(4):1002–1008.
   PubMed Web of Science ®Google Scholar
• Landowski CP, Bolanz KA, Suzuki Y, et al. Chemical inhibitors of the calcium entry channel TRPV6. Pharm Res. 2011;28(2):322–330. doi: 10.1007/s11095-010-0249-9
   PubMed Web of Science ®Google Scholar
• Kovacs G, Montalbetti N, Simonin A, et al. Inhibition of the human epithelial calcium channel TRPV6 by 2-aminoethoxydiphenyl borate (2-APB). Cell Calcium. 2012;52(6):468–480. doi: 10.1016/j.ceca.2012.08.005
   PubMed Web of Science ®Google Scholar
• Hofer A, Kovacs G, Zappatini A, et al. Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport. Bioorg Med Chem. 2013;21(11):3202–3213. pii. doi: 10.1016/j.bmc.2013.03.037S0968-0896(13)00253-8
   PubMed Web of Science ®Google Scholar
• Simonin C, Awale M, Brand M, et al. Optimization of TRPV6 calcium channel inhibitors using a 3D Ligand-based Virtual Screening Method. Angew Chem Int Ed Engl. 2015;54(49):14748–14752. doi: 10.1002/anie.201507320
   PubMed Web of Science ®Google Scholar
• Cunha MR, Bhardwaj R, Carrel AL, et al. Natural Product Inspired Optimization of a selective TRPV6 calcium channel inhibitor. RSC Med Chem. 2020;11:1032–1040. doi: 10.1039/D0MD00145G
   PubMedGoogle Scholar
• Cunha MR, Bhardwaj R, Lindinger S, et al. Photoswitchable inhibitor of the calcium channel TRPV6. ACS Med Chem Lett. 2019;10(9):1341–1345. doi: 10.1021/acsmedchemlett.9b00298
   PubMed Web of Science ®Google Scholar
• Fu S, Hirte H, Welch S, et al. First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors. Invest New Drugs pii. 2017;35:324–333. doi: 10.1007/s10637-017-0438-z
   PubMed Web of Science ®Google Scholar
• Xue H, Wang Y, MacCormack TJ, et al. Inhibition of transient receptor potential vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model. J Cancer. 2018;9(17):3196–3207. doi: 10.7150/jca.20639
   PubMed Web of Science ®Google Scholar
• Bowen CV, DeBay D, Ewart HS, et al. In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin. PLoS One. 2013;8(3):e58866. doi: 10.1371/journal.pone.0058866
   PubMed Web of Science ®Google Scholar
• Saotome K, Singh AK, Yelshanskaya MV, et al. Crystal structure of the epithelial calcium channel TRPV6. Nature. 2016;534(7608):506–511. doi: 10.1038/nature17975
   PubMed Web of Science ®Google Scholar
• McGoldrick LL, Singh AK, Saotome K, et al. Opening of the human epithelial calcium channel TRPV6. Nature. 2018;553(7687):233–237. doi: 10.1038/nature25182
   PubMed Web of Science ®Google Scholar
• Bhardwaj R, Lindinger S, Neuberger A, et al. Inactivation-mimicking block of the epithelial calcium channel TRPV6. Sci Adv. 2020;6(48):eabe1508. doi: 10.1126/sciadv.abe1508
   PubMed Web of Science ®Google Scholar
• Neuberger A, Nadezhdin KD, Sobolevsky AI. Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun. 2021;12(1):1–10. doi: 10.1038/s41467-021-26608-x
   PubMed Web of Science ®Google Scholar
• Neuberger A, Trofimov YA, Yelshanskaya MV, et al. Structural mechanism of human oncochannel TRPV6 inhibition by the natural phytoestrogen genistein. Nat Commun. 2023;14(1):1–13. doi: 10.1038/s41467-023-38352-5
   PubMed Web of Science ®Google Scholar
• Long SB, Tao X, Campbell EB, et al. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature. 2007;450(7168):376–382. doi: 10.1038/nature06265
   PubMed Web of Science ®Google Scholar
• Singh AK, Saotome K, Sobolevsky AI. Swapping of transmembrane domains in the epithelial calcium channel TRPV6. Sci Rep. 2017;7(1):1–10. doi: 10.1038/s41598-017-10993-9
   PubMedGoogle Scholar
• Yelshanskaya MV, Sobolevsky AI. Ligand-binding sites in vanilloid-Subtype TRP channels. Front Pharmacol. 2022;13:900623. doi: 10.3389/fphar.2022.900623
   PubMed Web of Science ®Google Scholar
• Lee J, Cha SK, Sun TJ, et al. PIP2 activates TRPV5 and releases its inhibition by intracellular Mg2+. J Gen Physiol. 2005;126(5):439–451. doi: 10.1085/jgp.200509314
   PubMed Web of Science ®Google Scholar
• Hughes TET, Pumroy RA, Yazici AT, et al. Structural insights on TRPV5 gating by endogenous modulators. Nat Commun. 2018;9:4198. doi: 10.1038/s41467-018-06753-6
   PubMed Web of Science ®Google Scholar
• Neuberger A, Nadezhdin KD, Sobolevsky AI. Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun. 2021;12(1):6284. doi: 10.1038/s41467-021-26608-x
   PubMed Web of Science ®Google Scholar
• Fluck EC, Yazici AT, Rohacs T, et al. Structural basis of TRPV5 regulation by physiological and pathophysiological modulators. Cell Rep. 2022;39(4):110737. doi: 10.1016/j.celrep.2022.110737
   PubMed Web of Science ®Google Scholar
• Fathizadeh A, Senning E, Elber R. Impact of the Protonation state of phosphatidylinositol 4,5-bisphosphate (PIP2) on the binding Kinetics and Thermodynamics to transient receptor potential vanilloid (TRPV5): A Milestoning study. J Phys Chem B. 2021;125(33):9547–9556. doi: 10.1021/acs.jpcb.1c04052
   PubMed Web of Science ®Google Scholar
• Lee BH, De Jesus Perez JJ, Moiseenkova-Bell V, et al. Structural basis of the activation of TRPV5 channels by long-chain acyl-Coenzyme-A. Nat Commun. 2023;14(1):5883. doi: 10.1038/s41467-023-41577-z
   PubMed Web of Science ®Google Scholar
• Bate N, Caves RE, Skinner SP, et al. A novel mechanism for calmodulin-dependent inactivation of transient receptor potential vanilloid 6. Biochem. 2018;57(18):2611–2622. doi: 10.1021/acs.biochem.7b01286
   PubMed Web of Science ®Google Scholar
• Kovalevskaya NV, Bokhovchuk FM, Vuister GW. The TRPV5/6 calcium channels contain multiple calmodulin binding sites with differential binding properties. J Struct Funct Genomics. 2012;13:91–100. doi: 10.1007/s10969-012-9128-4
   PubMedGoogle Scholar
• de Groot T, Kovalevskaya NV, Verkaart S, et al. Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone. Mol Cell Biol. 2011;31(14):2845–2853. doi: 10.1128/MCB.01319-10
   PubMed Web of Science ®Google Scholar
• Holakovska B, Grycova L, Bily J, et al. Characterization of calmodulin binding domains in TRPV2 and TRPV5 C-tails. Amino Acids. 2011;40(2):741–748. doi: 10.1007/s00726-010-0712-2
   PubMed Web of Science ®Google Scholar
• Dang S, Van Goor, MK, Asarnow, D et al. Structural insight into TRPV5 channel function and modulation. Proceedings of the National Academy of Sciences 116, 8869–8878. 2019.
   Google Scholar
• Zuidscherwoude M, van Goor MK, Roig SR, et al. Functional basis for calmodulation of the TRPV5 calcium channel. J Physiol. 2023;601(4):859–878. doi: 10.1113/JP282952
   PubMed Web of Science ®Google Scholar
• van der Wijst J, Leunissen EH, Blanchard MG, et al. A gate hinge controls the epithelial calcium channel TRPV5. Sci Rep. 2017;7(1):45489. doi: 10.1038/srep45489
   PubMedGoogle Scholar
• Nowak L, Bregestovski P, Ascher P, et al. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 1984;307(5950):462–465. doi: 10.1038/307462a0
   PubMed Web of Science ®Google Scholar
• Sobolevsky AI, Yelshansky MV. The trapping block of NMDA receptor channels in acutely isolated rat hippocampal neurones. J Physiol. 2000;526(3):493–506. doi: 10.1111/j.1469-7793.2000.t01-2-00493.x
   PubMed Web of Science ®Google Scholar
• Suh BC, Hille B. Electrostatic interaction of internal Mg2+ with membrane PIP2 Seen with KCNQ K+ channels. J Gen Physiol. 2007;130(3):241–256. doi: 10.1085/jgp.200709821
   PubMed Web of Science ®Google Scholar
• Liao M, Cao E, Julius D, et al. Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature. 2013;504(7478):107–112. doi: 10.1038/nature12822
   PubMed Web of Science ®Google Scholar
• Cao E, Liao M, Cheng Y, et al. TRPV1 structures in distinct conformations reveal activation mechanisms. Nature. 2013;504(7478):113–118. doi: 10.1038/nature12823
   PubMed Web of Science ®Google Scholar
• Neuberger A, Oda M, Nikolaev YA, et al. Human TRPV1 structure and inhibition by the analgesic SB-366791. Nat Commun. 2023;14(1):2451. doi: 10.1038/s41467-023-38162-9
   PubMed Web of Science ®Google Scholar
• Singh AK, Saotome K, McGoldrick LL, et al. Structural bases of TRP channel TRPV6 allosteric modulation by 2-APB. Nat Commun. 2018;9(1):1–11. doi: 10.1038/s41467-018-04828-y
   PubMedGoogle Scholar
• Clarke MJ. Ruthenium metallopharmaceuticals. Coordin Chem Rev. 2002;232(1–2):69–93. doi: 10.1016/S0010-8545(02)00025-5
   Web of Science ®Google Scholar
• Tapia R, Velasco I. Ruthenium red as a tool to study calcium channels, neuronal death and the function of neural pathways. Neurochem Int. 1997;30(2):137–147. doi: 10.1016/s0197-0186(96)00056-3
   PubMed Web of Science ®Google Scholar
• Yamada K. Dual staining of some sulfated mucopolysaccharides with alcian blue (pH 1.0) and ruthenium red (pH 2.5). Histochemie. 1970;23(1):13–20. doi: 10.1007/BF00309485
   PubMedGoogle Scholar
• Pope L, Lolicato M, Minor DL Jr. Polynuclear ruthenium Amines inhibit K2P channels via a “Finger in the Dam” mechanism. Cell Chem Biol. 2020;27(5):511–524.e4. doi: 10.1016/j.chembiol.2020.01.011
   PubMed Web of Science ®Google Scholar
• Choi W, Clemente N, Sun W, et al. The structures and gating mechanism of human calcium homeostasis modulator 2. Nature. 2019;576(7785):163–167. doi: 10.1038/s41586-019-1781-3
   PubMed Web of Science ®Google Scholar
• Nelson AM, Moayedi Y, Greenberg SA et al. 2-APB arrests human keratinocyte proliferation and inhibits cutaneous squamous cell carcinoma in vitro. bioRxiv. 2018;249821. doi:10.1101/249821.
   Google Scholar
• Maruyama T, Kanaji T, Nakade S, et al. 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4, 5)P3-induced Ca2+ release. The Journal Of Biochemistry. 1997;122(3):498–505. doi: 10.1093/oxfordjournals.jbchem.a021780
   PubMed Web of Science ®Google Scholar
• Togashi K, Inada H, Tominaga M. Inhibition of the transient receptor potential cation channel TRPM2 by 2‐aminoethoxydiphenyl borate (2‐APB). Br J Pharmacol. 2008;153(6):1324–1330. doi: 10.1038/sj.bjp.0707675
   PubMed Web of Science ®Google Scholar
• Lievremont J-P, Bird GS, Putney JW. Mechanism of inhibition of TRPC cation channels by 2-aminoethoxydiphenylborane. Mol Pharmacol. 2005;68(3):758–762. doi: 10.1124/mol.105.012856
   PubMed Web of Science ®Google Scholar
• Chokshi R, Fruasaha P, Kozak JA. 2-aminoethyl diphenyl borinate (2-APB) inhibits TRPM7 channels through an intracellular acidification mechanism. Channels. 2012;6(5):362–369. doi: 10.4161/chan.21628
   PubMed Web of Science ®Google Scholar
• Thienpont D, Van Cutsem J, Van Nueten J, et al. Biological and toxicological properties of econazole, a broad-spectrum antimycotic. Arzneimittel-forschung. 1975;25(2):224–230.
   PubMed Web of Science ®Google Scholar
• Wyler R, Murbach A, Möhl H. An imidazole derivative (econazole) as an antifungal agent in cell culture systems. In Vitro. 1979;15(10):745–750. doi: 10.1007/BF02618300
   PubMedGoogle Scholar
• Heel R, Brogden R, Speight T, et al. Econazole: a review of its antifungal activity and therapeutic efficacy. Drugs. 1978;16(3):177–201. doi: 10.2165/00003495-197816030-00001
   PubMed Web of Science ®Google Scholar
• Schwarz EC, Wissenbach U, Niemeyer BA, et al. TRPV6 potentiates calcium-dependent cell proliferation. Cell Calcium. 2006;39(2):163–173. doi: 10.1016/j.ceca.2005.10.006
   PubMed Web of Science ®Google Scholar
• Nilius B, Prenen J, Vennekens R, et al. Pharmacological modulation of monovalent cation currents through the epithelial Ca2+ channel ECaC1. Br J Pharmacol. 2001;134(3):453–462. doi: 10.1038/sj.bjp.0704272
   PubMed Web of Science ®Google Scholar
• Neuberger A, Oraiopoulos N, Drakeman DL. In drug Discovery Today. 2019;24(1):1–3.
   Google Scholar
• Neuberger A, Oraiopoulos N, Drakeman DL. Lemons, or squeezed for resources? Information symmetry and asymmetric resources in biotechnology. Front Pharmacol. 2017;8:338. doi: 10.3389/fphar.2017.00338
   PubMed Web of Science ®Google Scholar
• Yelshanskaya MV, Sobolevsky AI. Ligand-binding sites in vanilloid-Subtype TRP channels. Front Pharmacol. 2022;13. doi: 10.3389/fphar.2022.900623
   PubMed Web of Science ®Google Scholar
• Bhattaram VA, Graefe U, Kohlert C, et al. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine. 2002;9:1–33. doi: 10.1078/1433-187X-00210
   PubMed Web of Science ®Google Scholar
• Neuberger A, Nadezhdin KD, Zakharian E, et al. Structural mechanism of TRPV3 channel inhibition by the plant‐derived coumarin osthole. EMBO Rep. 2021;22(11):e53233. doi: 10.15252/embr.202153233
   PubMed Web of Science ®Google Scholar
• Neuberger A, Trofimov YA, Yelshanskaya MV, et al. Molecular pathway and structural mechanism of human oncochannel TRPV6 inhibition by the phytocannabinoid tetrahydrocannabivarin. Nat Commun. 2023. forthcomingearly August. doi: 10.1038/s41467-023-40362-2.
   Web of Science ®Google Scholar
• Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chemistry & Biodiversity. 2007;4(8):1614–1648. doi: 10.1002/cbdv.200790144
   PubMed Web of Science ®Google Scholar
• Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci. 2022;9(4):413–430.
   Google Scholar
• Muller C, Morales P, Reggio PH. Cannabinoid ligands targeting TRP channels. Front Mol Neurosci. 2019;11:487. doi:10.3389/fnmol.2018.00487
   PubMed Web of Science ®Google Scholar
• Pumroy RA, Protopopova AD, Fricke TC, et al. Structural insights into TRPV2 activation by small molecules. Nat Commun. 2022;13(1):1–12. doi: 10.1038/s41467-022-30083-3
   PubMed Web of Science ®Google Scholar
• Pumroy RA, Samanta A, Liu Y, et al. Molecular mechanism of TRPV2 channel modulation by cannabidiol. Elife. 2019;8:e48792. doi: 10.7554/eLife.48792
   PubMed Web of Science ®Google Scholar
• Neuberger A, Nadezhdin KD, Sobolevsky AI. Structural mechanism of TRPV3 channel inhibition by the anesthetic dyclonine. Nat Commun. 2022;13(1):1–9. doi: 10.1038/s41467-022-30537-8
   PubMed Web of Science ®Google Scholar
• Janssens A, Silvestri C, Martella A, et al. Δ9-tetrahydrocannabivarin impairs epithelial calcium transport through inhibition of TRPV5 and TRPV6. Pharmacol Res. 2018;136:83–89. DOI:10.1016/j.phrs.2018.08.021
   PubMed Web of Science ®Google Scholar
• Dixon RA, Ferreira DG. Phytochemistry. 2002;60:205–211. doi: 10.1016/S0031-9422(02)00116-4
   PubMed Web of Science ®Google Scholar
• Banerjee S, Li Y, Wang Z, et al. Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008;269(2):226–242. doi: 10.1016/j.canlet.2008.03.052
   PubMed Web of Science ®Google Scholar
• Bhagwat S, Haytowitz DB, Holden JM. USDA database for the isoflavone content of selected foods, release 2.0. Maryland: US Department Of Agriculture. 2008;15:1–67.
   Google Scholar
• Liggins J, Bluck LJC, Runswick S, et al. Daidzein and genistein contents of vegetables. British Journal Of Nutrition. 2000;84(5):717–725. doi: 10.1017/S0007114500002075
   PubMed Web of Science ®Google Scholar
• Pintova S, Dharmupari S, Moshier E, et al. Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: Phase I/II pilot study. Cancer Chemother Pharmacol. 2019;84:591–598. doi: 10.1007/s00280-019-03886-3
   PubMed Web of Science ®Google Scholar
• Pavese JM, Farmer RL, Bergan RC. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metast Rev. 2010;29(3):465–482. doi: 10.1007/s10555-010-9238-z
   PubMed Web of Science ®Google Scholar
• Huang X, Chen S, Xu L, et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res. 2005;65(8):3470–3478. doi: 10.1158/0008-5472.CAN-04-2807
   PubMed Web of Science ®Google Scholar
• Lakshman M, Xu L, Ananthanarayanan V, et al. Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res. 2008;68(6):2024–2032. doi: 10.1158/0008-5472.CAN-07-1246
   PubMed Web of Science ®Google Scholar
• Xu L, Bergan RC. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor β-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway. Mol Pharmacol. 2006;70:869–877. doi: 10.1124/mol.106.023861
   PubMed Web of Science ®Google Scholar
• Xu L, Ding Y, Catalona WJ, et al. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. JNCI. 2009;101(16):1141–1155. doi: 10.1093/jnci/djp227
   PubMedGoogle Scholar
• Scholar EM, Toews ML. Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett. 1994;87(2):159–162. doi: 10.1016/0304-3835(94)90217-8
   PubMed Web of Science ®Google Scholar
• Li Y, Sarkar FH. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett. 2002;186(2):157–164. doi: 10.1016/S0304-3835(02)00349-X
   PubMed Web of Science ®Google Scholar
• Nakamura A, Aizawa J, Sakayama K, et al. Genistein inhibits cell invasion and motility by inducing cell differentiation in murine osteosarcoma cell line LM8. BMC Cell Biol. 2012;13(1):1–10. doi: 10.1186/1471-2121-13-24
   PubMedGoogle Scholar
• Fritz WA, Coward L, Wang J, et al. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis. 1998;19:2151–2158. doi:10.1093/carcin/19.12.2151
   PubMed Web of Science ®Google Scholar
• Lamartiniere CA. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr. 2000;71(6):1705S–1707S. doi: 10.1093/ajcn/71.6.1705S
   PubMed Web of Science ®Google Scholar
• Yanagihara K, Ito A, Toge T, et al. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 1993;53:5815–5821.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee J, Gourley L, et al. Dietary effects on breast-cancer risk in Singapore. Lancet. 1991;337(8751):1197–1200. doi: 10.1016/0140-6736(91)92867-2
   PubMed Web of Science ®Google Scholar
• Uckun F, Evans WE, Forsyth CJ, et al. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science. 1995;267(5199):886–891. doi: 10.1126/science.7531365
   PubMed Web of Science ®Google Scholar
• Harper CE, Cook LM, Patel BB, et al. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV‐40 tag rats. Prostate. 2009;69(15):1668–1682. doi: 10.1002/pros.21017
   PubMed Web of Science ®Google Scholar
• Shafiee G, Saidijam M, Tayebinia H, et al. Beneficial effects of genistein in suppression of proliferation, inhibition of metastasis, and induction of apoptosis in PC3 prostate cancer cells. Arch Physiol Biochem. 2022;128(3):694–702. doi: 10.1080/13813455.2020.1717541
   PubMed Web of Science ®Google Scholar
• Imai-Sumida M, Dasgupta P, Kulkarni P, et al. Genistein represses HOTAIR/chromatin remodeling pathways to suppress kidney cancer. Cell Physiol Biochem. 2020;54:53.
   PubMedGoogle Scholar
• Davis JN, Kucuk O, Sarkar FH. Genistein inhibits NF-kB activation in prostate cancer cells. Nutr Cancer. 1999;35(2):167–174. doi: 10.1207/S15327914NC352_11
   PubMed Web of Science ®Google Scholar
• Sarkar FH, Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metast Rev. 2002;21(3/4):265–280. doi: 10.1023/A:1021210910821
   PubMed Web of Science ®Google Scholar
• Lamartiniere CA, Moore J, Holland M, et al. Neonatal genistein chemoprevents mammary cancer. Proceedings of the Society for Experimental Biology and Medicine 208, 120–123 (1995).
   Google Scholar
• Gossner G, CHOI M, TAN L, et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol. 2007;105(1):23–30. doi: 10.1016/j.ygyno.2006.11.009
   PubMed Web of Science ®Google Scholar
• Pagliacci M, Smacchia M, Migliorati G, et al. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer. 1994;30(11):1675–1682. doi: 10.1016/0959-8049(94)00262-4
   Web of Science ®Google Scholar
• Lamartiniere CA, Moore JB, Brown NM, et al. Genistein suppresses mammary cancer in rats. Carcinogenesis. 1995;16(11):2833–2840. doi: 10.1093/carcin/16.11.2833
   PubMed Web of Science ®Google Scholar
• Li Y, Sarkar FH. Gene expression profiles of genistein-treated PC3 prostate cancer cells. J Nutr. 2002;132(12):3623–3631. doi: 10.1093/jn/132.12.3623
   PubMed Web of Science ®Google Scholar
• Cappelletti V, Fioravanti L, Miodini P, et al. Genistein blocks breast cancer cells in the G2M phase of the cell cycle. J Cell Biochem. 2000;79(4):594–600. doi: 10.1002/1097-4644(20001215)79:4<594:AID-JCB80>3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Chen W-F, Huang M-H, Tzang C-H, et al. Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim Biophys Acta Mol Basis Dis. 2003;1638:187–196. doi: 10.1016/S0925-4439(03)00082-6
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Kim HS, Song Y-S. Genistein as a potential anticancer agent against ovarian cancer. J Tradit Complement Med. 2012;2(2):96–104. doi: 10.1016/S2225-4110(16)30082-7
   PubMedGoogle Scholar
• Lian F, Li Y, Bhuiyan M, et al. H. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer. 1999;33(2):125–131. doi: 10.1207/S15327914NC330202
   PubMed Web of Science ®Google Scholar
• Ma J, Cheng L, Liu H, et al. Genistein down-regulates miR-223 expression in pancreatic cancer cells. Curr Drug Targets. 2013;14(10):1150–1156. doi: 10.2174/13894501113149990187
   PubMed Web of Science ®Google Scholar
• Murrill WB, Brown NM, Zhang JX, et al. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis. 1996;17:1451–1458. doi: 10.1093/carcin/17.7.1451
   PubMed Web of Science ®Google Scholar
• Yu Z, Li W, Liu F. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett. 2004;215(2):159–166. doi: 10.1016/j.canlet.2004.06.010
   PubMed Web of Science ®Google Scholar
• Gong L, Li Y, Nedeljkovic-Kurepa A, et al. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene. 2003;22(30):4702–4709. doi: 10.1038/sj.onc.1206583
   PubMed Web of Science ®Google Scholar
• Wang J, Eltoum I-E, Lamartiniere CA. Dietary genistein suppresses chemically induced prostate cancer in Lobund–Wistar rats. Cancer Lett. 2002;186(1):11–18. doi: 10.1016/S0304-3835(01)00811-4
   PubMed Web of Science ®Google Scholar
• Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000;71(6):1462–1469. doi: 10.1093/ajcn/71.6.1462
   PubMed Web of Science ®Google Scholar
• Peluso MR, Winters TA, Shanahan MF, et al. A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J Nutr. 2000;130(9):2333–2342. doi: 10.1093/jn/130.9.2333
   PubMed Web of Science ®Google Scholar
• Hwang J, Hodis HN, Sevanian A. Soy and alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chemistry. 2001;49(1):308–314. doi: 10.1021/jf0007028
   PubMed Web of Science ®Google Scholar
• File SE, Jarrett N, Fluck E, et al. Eating soya improves human memory. Psychopharmacology. 2001;157(4):430–436. doi: 10.1007/s002130100845
   PubMed Web of Science ®Google Scholar
• Alekel DL, Germain AS, Peterson CT, et al. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr. 2000;72(3):844–852. doi: 10.1093/ajcn/72.3.844
   PubMed Web of Science ®Google Scholar
• Phetnoo N, Werawatganon D, Siriviriyakul P. Genistein could have a therapeutic potential for gastrointestinal diseases. Thai J Gastroenterol. 2013;14:120–125.
   Google Scholar
• Marini H, Minutoli L, Polito F, et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann internal med. 2007;146(12):839–847. doi: 10.7326/0003-4819-146-12-200706190-00005
   PubMed Web of Science ®Google Scholar
• Li B, Yu S. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol Pharm Bull. 2003;26(6):780–786. doi: 10.1248/bpb.26.780
   PubMed Web of Science ®Google Scholar
• Lu R, Zheng Z, Yin Y, et al. Genistein prevents bone loss in type 2 diabetic rats induced by streptozotocin. Food & Nutrition Research. 2020;64. doi: 10.29219/fnr.v64.3666
   Web of Science ®Google Scholar
• Albertazzi P. Purified phytoestrogens in postmenopausal bone health: is there a role for genistein? Climacteric. 2002;5(2):190–196. doi: 10.1080/cmt.5.2.190.196
   PubMed Web of Science ®Google Scholar
• Pavese JM, Krishna SN, Bergan RC. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. Am J Clin Nutr. 2014;100:431S–436S. doi:10.3945/ajcn.113.071290
   PubMed Web of Science ®Google Scholar
• Squadrito F, Marini H, Bitto A, et al. Genistein in the metabolic syndrome: results of a randomized clinical trial. J Clin Endocrinol Metab. 2013;98(8):3366–3374. doi: 10.1210/jc.2013-1180
   PubMed Web of Science ®Google Scholar
• Smart OS, Neduvelil JG, Wang X, et al. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J Mol Graph. 1996;14:354–360. doi:10.1016/S0263-7855(97)00009-X
   PubMedGoogle Scholar